Methods of preventing sustained monomorphic ventricular tachycardia
following myocardial ischemia, decreasing infarct size and/or decreasing
the incidence and/or maximum intrinsic rate of very rapid ventricular
triplets following myocardial ischemia is disclosed. The methods involve
administering an effective amount of a composition that inhibits
substantial loss of beta-adrenergic receptor kinase (.beta.-ARK) activity
and/or .beta.-ARK expression.